LivingGLP1
Condition P99

Other conditions

Any other condition studied in a randomized trial of a GLP-1 receptor agonist containing drug. Each condition receives its own population code by amendment when its first eligible trial is included.

63 randomized trials; 0 fitted analyses across 0 outcomes.

All outcomes

Each outcome is analyzed per time window and estimand, with doses kept apart (each dose) and pooled (each medicine). Analyses with too few connected trials are shown as descriptive.